logo

For the Inventor, By the Inventor

Cambridge, MA, United States of America

Ying Ou

This inventor holds 3 USPTO granted patents. Top assignee: Beigene Switzerland Gmbh. Active years: 2023-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ying Ou. Retrieved from https://idiyas.com/inventor/ying-ou-webo1em4

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3

% Patents Active = 100.0

Average Co-Inventor Count = 3.6

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Cambridge, MA (US) (2023)
  • Palo Alto, CA (US) (2024)

Company Filing History:

goldMedal3 out of 22 
 
Beigene Switzerland Gmbh
 patents

Years Active: 2023-2024

Loading Chart...
3 patents (USPTO):Explore Patents
1. 11911386 - Methods of treating B-cell proliferative disorder (2024-02-27),
2. 11896596 - Methods of treating B-cell proliferative disorder (2024-02-13),
3. 11786531 - Methods of treating B-cell proliferative disorder (2023-10-17),

Title: Innovations by Inventor Ying Ou

Introduction

Ying Ou is a notable inventor based in Cambridge, MA (US), recognized for his contributions to the field of medicine. He holds a total of three patents, showcasing his innovative approaches to treating B-cell proliferative disorders.

Latest Patents

Among his latest patents is a method of treating patients with B-cell proliferative disorders. This method involves administering zanubrutinib, or a pharmaceutically acceptable salt thereof, to patients who are characterized by being treated with a moderate CYP3A inducer. In one embodiment, the dosage of zanubrutinib is approximately 320 mg twice a day, leading to a total daily dose of about 640 mg. This innovative treatment method aims to improve patient outcomes in managing B-cell proliferative disorders.

Career Highlights

Ying Ou is currently associated with Beigene Switzerland GmbH, where he continues to develop and refine his innovative medical treatments. His work is pivotal in advancing therapeutic options for patients suffering from complex health conditions.

Collaborations

Ying Ou collaborates with talented professionals in his field, including Jason Paik and Tommi Salmi. These collaborations enhance the research and development efforts at Beigene Switzerland GmbH, contributing to the advancement of medical science.

Conclusion

Ying Ou's innovative work in treating B-cell proliferative disorders exemplifies the impact of dedicated inventors in the medical field. His patents and collaborations reflect a commitment to improving patient care through scientific advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…